AMAP RISK SCORE PREDICTS HEPATOCELLULAR CARCINOMA DEVELOPMENT IN CHRONIC HEPATITIS PATIENTS: AN INTERNATIONAL COHORT COLLABORATION

被引：0

作者：

Fan, Rong ^{[1
]}

Papatheodoridis, George ^{[2
]}

Sun, Jian ^{[1
]}

Innes, Hamish ^{[3
]}

Toyoda, Hidenori ^{[4
]}

Xie, Qing ^{[5
]}

Mo, Shuyuan ^{[6
]}

Sypsa, Vana ^{[7
]}

Guha, Indra Neil ^{[8
,9
]}

Kumada, Takashi ^{[10
]}

Niu, Junqi ^{[11
]}

Dalekos, George ^{[12
]}

Yasuda, Satoshi ^{[4
]}

Barnes, Eleanor ^{[13
,14
]}

Lian, Jianqi ^{[15
]}

Suri, Vithika ^{[6
]}

Idilman, Ramazan ^{[16
]}

Barclay, Stephen T. ^{[17
]}

Dou, Xiaoguang ^{[18
]}

Berg, Thomas ^{[19
]}

Hayes, Peter C. ^{[20
]}

Flaherty, John F. ^{[6
]}

Zhou, Yuanping ^{[1
]}

Zhang, Zhengang ^{[21
]}

Buti Ferret, Maria Asuncion ^{[22
,23
]}

Hutchinson, Sharon J. ^{[3
]}

Guo, Yabing ^{[24
]}

Luis Calleja, Jose ^{[25
]}

Lin, Lanjia ^{[6
]}

Zhao, Longfeng ^{[26
]}

Chen, Yongpeng ^{[1
]}

Janssen, Harry L. A. ^{[27
]}

Zhu, Chaonan ^{[28
]}

Shi, Lei ^{[28
]}

Tang, Xiaoping ^{[29
]}

Gaggar, Anuj ^{[6
]}

Wei, Lai ^{[30
]}

Jia, Ji Dong ^{[31
]}

Irving, William L. ^{[8
,9
]}

Johnson, Philip ^{[32
]}

Lampertico, Pietro ^{[33
,34
]}

Hou, JinLin ^{[1
]}

机构：

[1] Southern Med Univ, Dept Infect Dis, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China

[2] Natl & Kapodistrian Univ Athens, Dept Gastroenterol, Gen Hosp Athens Laiko, Sch Med, Athens, Greece

[3] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Glasgow, Lanark, Scotland

[4] Ogaki Municipal Hosp, Dept Gastroenterol & Hepatol, Ogaki, Japan

[5] Shanghai Jiao Tong Univ, Sch Med, Dept Infect Dis, Ruijin Hosp, Shanghai, Peoples R China

[6] Gilead Sci Inc, Foster City, CA 94404 USA

[7] Natl & Kapodistrian Univ Athens, Dept Hyg Epidemiol & Med Stat, Sch Med, Athens, Greece

[8] Nottingham Univ Hosp NHS Trust, Nihr Nottingham Biomed Res Ctr, Nottingham, England

[9] Univ Nottingham, Nottingham, England

[10] Gifu Kyoritsu Univ, Dept Nursing, Ogaki, Japan

[11] Jilin Univ, Dept Hepatol, Hosp 1, Changchun, Jilin, Peoples R China

[12] Thessalia Univ, Dept Internal Med, Sch Med, Thessaly, Greece

[13] Univ Oxford, Nuffield Dept Med, Peter Medawar Bldg Pathogen Res, Oxford, England

[14] Univ Oxford, Oxford Nihr Biomed Res Ctr, Oxford, England

[15] Fourth Mil Med Univ, Ctr Infect Dis, Tangdu Hosp, Xian, Peoples R China

[16] Ankara Univ, Sch Med, Dept Gastroenterol, Ankara, Turkey

[17] Glasgow Royal Infirm, Glasgow, Lanark, Scotland

[18] China Med Univ, Dept Infect Dis, Shengjing Hosp, Taichung, Taiwan

[19] Univ Leipzig, Div Hepatol, Dept Med 2, Med Ctr, Leipzig, Germany

[20] Royal Infirm Edinburgh NHS Trust, Edinburgh, Midlothian, Scotland

[21] Huazhong Univ Sci & Technol, Dept Gastroenterol, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China

[22] Hosp Gen Univ Valle Hebron, Barcelona, Spain

[23] Ciberehd, Barcelona, Spain

[24] Nan Fang Hosp, Tumors Liver, Guangzhou, Guangdong, Peoples R China

[25] Hosp Univ Puerta De Hierro, Idiphim Ciberehd, Barcelona, Spain

[26] Shanxi Med Univ, Dept Infect Dis, Hosp 1, Taiyuan, Shanxi, Peoples R China

[27] Univ Hlth Network, Liver Clin, Toronto Western & Gen Hosp, Toronto, ON, Canada

[28] Hangzhou Yitu Healthcare Technol Co Ltd, Big Data Res & Biostat Ctr, Hangzhou, Zhejiang, Peoples R China

[29] Guangzhou Eighth Peoples Hosp, Guangzhou, Guangdong, Peoples R China

[30] Peking Univ, Peoples Hosp, Inst Hepatol, Beijing, Peoples R China

[31] Capital Med Univ, Liver Res Ctr, Beijing Friendship Hosp, Beijing, Peoples R China

[32] Univ Liverpool, Dept Mol & Clin Canc Med, Liverpool, Merseyside, England

[33] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy

[34] Fdn Irccs Ca Granda Osped Maggiore Policlin, Div Gastroenterol & Hepatol, CRC AM & A Miglievacce Ctr Liver Dis, Milan, Italy

来源：

HEPATOLOGY | 2020年 / 72卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

134

引用

页码：97A / 98A

页数：2

共 50 条

[21] Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients
Ohki, Takamasa
Tateishi, Ryosuke
Sato, Takahisa
Masuzaki, Ryota
Imamura, Jun
Goto, Tadashi
Yamashiki, Noriyo
Yoshida, Hideo
Kanai, Fumihiko
Kato, Naoya
Shiina, Shuichiro
Yoshida, Haruhiko
Kawabe, Takao
Omata, Masao
[J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (04) : 459 - 464
[22] Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B
Wong, Grace Lai-Hung
Chan, Henry Lik-Yuen
Wong, Catherine Ka-Yan
Leung, Calvin
Chan, Candace Yim
Ho, Patricia Po-Lai
Chung, Vivian Chi-Yee
Chan, Zhan Cham-Yan
Tse, Yee-Kit
Chim, Angel Mei-Ling
Lau, Tina Kit-Ting
Wong, Vincent Wai-Sun
[J]. JOURNAL OF HEPATOLOGY, 2014, 60 (02) : 339 - 345
[23] TREATMENT RESPONSE OF NONINVASIVE FIBROSIS MARKERS PREDICTS HEPATOCELLULAR CARCINOMA DEVELOPMENT IN CHRONIC HEPATITIS B PATIENTS
Nam, Heechul
Jang, Jeong Won
Kwon, Jung Hyun
Yoo, Sun Hong
Nam, Soon Woo
Lee, Sung Won
Lee, Hae Lim
Bae, Si Hyun
Sung, Pil Soo
Yang, Hyun
Choi, Jong Young
Yoon, Seung Kew
Lee, Soon Kyu
Tak, Kwon Yong
[J]. HEPATOLOGY, 2019, 70 : 294A - 294A
[24] Quantitative hepatitis B surface antigen predicts the antiviral response and hepatocellular carcinoma development in patients with chronic hepatitis B
Kim, Sung Eun
[J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (04): : 631 - 633
[25] Risk stratification for hepatocellular carcinoma in patients with chronic hepatitis D
Steinhoff, Leonie
Jeschke, Matthias
Jochheim, Leonie
Hild, Benedikt
Passenberg, Moritz
Schmidt, Hartmut
Schramm, Christoph
[J]. JOURNAL OF HEPATOLOGY, 2023, 78 : S1125 - S1126
[26] Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score
Yang, Hwai-I
Yuen, Man-Fung
Chan, Henry Lik-Yuen
Han, Kwang-Hyub
Chen, Pei-Jer
Kim, Do-Young
Ahn, Sang-Hoon
Chen, Chien-Jen
Wong, Vincent Wai-Sun
Seto, Wai-Kay
[J]. LANCET ONCOLOGY, 2011, 12 (06): : 568 - 574
[27] A Cohort Study to Investigate Hepatocellular Carcinoma Risk In Hepatitis C Patients
Wang, Chun-Hsiang
Mo, Lein-Ray
Chang, Kuo-Kwan
Lin, Ruey-Chang
Kuo, Jen-Juan
[J]. HEPATO-GASTROENTEROLOGY, 2011, 58 (107) : 904 - 908
[28] Risk score model for the development of hepatocellular carcinoma in treatment-naive patients receiving oral antiviral treatment for chronic hepatitis B
Sohn, Won
Cho, Ju-Yeon
Kim, Ji Hoon
Lee, Jung Il
Kim, Hyung Joon
Woo, Min-Ah
Jung, Sin-Ho
Paik, Yong-Han
[J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2017, 23 (02) : 170 - 178
[29] THE RISK OF HEPATOCELLULAR CARCINOMA DEPENDING ON LIVER CIRRHOSIS IN PATIENTS WITH CHRONIC HEPATITIS C: A NATIONAL COHORT STUDY
Chang, Jong-In
Seo, Gi Hyeon
Kim, Eunju
Cho, Young Youn
Kim, Hyung Joon
[J]. HEPATOLOGY, 2023, 78 : S712 - S712
[30] aMAP score prediction of hepatocellular carcinoma occurrence and incidence-free rate after a sustained virologic response in chronic hepatitis C
Yamashita, Yuki
Joshita, Satoru
Sugiura, Ayumi
Yamazaki, Tomoo
Kobayashi, Hiroyuki
Wakabayashi, Shun-ichi
Yamada, Yosuke
Shibata, Soichiro
Kunimoto, Hideo
Iwadare, Takanobu
Matsumura, Makiko
Miyabayashi, Chiharu
Okumura, Taiki
Ozawa, Sachie
Nozawa, Yuichi
Kobayashi, Natsuko
Komatsu, Michiharu
Fujimori, Naoyuki
Saito, Hiromi
Umemura, Takeji
[J]. HEPATOLOGY RESEARCH, 2021, 51 (09) : 933 - 942

← 1 2 3 4 5 →